Cargando…
Molecular mechanism of diabetic cardiomyopathy and modulation of microRNA function by synthetic oligonucleotides
Diabetic cardiomyopathy (DCM) is a chronic complication in individuals with diabetes and is characterized by ventricular dilation and hypertrophy, diastolic dysfunction, decreased or preserved systolic function and reduced ejection fraction eventually resulting in heart failure. Despite being well c...
Autores principales: | Ghosh, Nilanjan, Katare, Rajesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863891/ https://www.ncbi.nlm.nih.gov/pubmed/29566757 http://dx.doi.org/10.1186/s12933-018-0684-1 |
Ejemplares similares
-
Exercise mediated protection of diabetic heart through modulation of microRNA mediated molecular pathways
por: Lew, Jason Kar Sheng, et al.
Publicado: (2017) -
Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease
por: Rawal, Shruti, et al.
Publicado: (2014) -
Exosomal microRNAs in diabetic heart disease
por: Chandrasekera, Dhananjie, et al.
Publicado: (2022) -
Inhibition of microRNA function by antimiR oligonucleotides
por: Stenvang, Jan, et al.
Publicado: (2012) -
The Potential Role of MicroRNA in Diabetic Cardiomyopathy
por: Kim, Jin Hwa
Publicado: (2020)